JBJ-09-063

N/A

Report date: 2026/01/14 17:56:15
NME

Base Information

Drug NameJBJ-09-063
Drug Alias NameJBJ-09-063
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR C797S inhibitors
TargetsEGFR C797S
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer Institute
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A